The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Subthreshold Nanosecond Laser Intervention in Age-Related Macular Degeneration
Open accessAbstract
Purpose There is an urgent need for a more effective intervention to slow or prevent progression of age-related macular degeneration (AMD) from its early stages to vision-threatening late complications. Subthreshold nanosecond laser (SNL) treatment has shown promise in preclinical studies and a pilot study in intermediate AMD (iAMD) as a potential treatment. We aimed to evaluate the safety of SNL treatment in iAMD and its efficacy for slowing progression to late AMD. Design The Laser Intervention in Early Stages of Age-Related Macular Degeneration (LEAD) study is a 36-month, multicenter, randomized, sham-controlled trial. Participants Two hundred ninety-two participants with bilateral large drusen and without OCT signs of atrophy. Methods Participants were assigned randomly to receive Retinal Rejuvenation Therapy (2RT ® ; Ellex Pty Ltd, Adelaide, Australia) SNL or sham treatment to the study eye at 6-monthly intervals. Main Outcome Measures The primary efficacy outcome was the time to development of late AMD defined by multimodal imaging (MMI). Safety was assessed by adverse events. Results Overall, progression to late AMD was not slowed significantly with SNL treatment compared with sham treatment (adjusted hazard ratio [HR], 0.61; 95% confidence interval [CI], 0.33–1.14; P = 0.122). However, a post hoc analysis showed evidence of effect modification based on the coexistence of reticular pseudodrusen (RPD; adjusted interaction P = 0.002), where progression was slowed for the 222 participants (76.0%) without coexistent RPD at baseline (adjusted HR, 0.23; 95% CI, 0.09–0.59; P = 0.002), whereas an increased progression rate (adjusted HR, 2.56; 95% CI, 0.80–8.18; P = 0.112) was observed for the 70 participants (24.0%) with RPD with SNL treatment. Differences between the groups in serious adverse events were not significant. Conclusions In participants with iAMD without MMI-detected signs of late AMD, no significant difference in the overall progression rate to late AMD between those receiving SNL and sham treatment were observed. However, SNL treatment may have a role in slowing progression for those without coexistent RPD and may be inappropriate in those with RPD, warranting caution when considering treatment in clinical phenotypes with RPD. Our findings provide compelling evidence for further trials of the 2RT ® laser, but they should not be extrapolated to other short-pulse lasers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Gal, A., Li, Y., Thompson, D. A., Weir, J., Orth, U., Jacobson, S. G., Apfelstedt-Sylla, E., & Vollrath, D. (2000) · Nature Genetics · doi:10.1038/81555 · Cited by 679
The dynamic nature of Bruch's membrane
Booij, J. C., Baas, D. C., Beisekeeva, J., Gorgels, T. G. M. F., & Bergen, A. A. B. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.08.003 · Cited by 581
Curcio, C. A., Messinger, J. D., Sloan, K. R., McGwin, G., Medeiros, N. E., & Spaide, R. F. (2013) · Retina · doi:10.1097/iae.0b013e31827e25e0 · Cited by 384
Retinal structure in vitamin A deficiency as explored with multimodal imaging
Aleman, T. S., Garrity, S. T., & Brucker, A. J. (2013) · Documenta Ophthalmologica · doi:10.1007/s10633-013-9403-0 · Cited by 81
Friberg, T. R., Musch, D. C., Lim, J. I., Morse, L., Freeman, W., & Sinclair, S. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.10.066 · Cited by 61
Owens, S. L., Bunce, C., Brannon, A. J., Xing, W., Chisholm, I. H., Gross, M., Guymer, R. H., Holz, F. G., & Bird, A. C. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.08.019 · Cited by 42
Self-citation
Cited by
Age-related macular degeneration
Fleckenstein, M., Keenan, T. D. L., Guymer, R. H., Chakravarthy, U., Schmitz-Valckenberg, S., Klaver, C. C., Wong, W. T., & Chew, E. Y. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00265-2 · Cited by 978
Self-citationAge-related macular degeneration
Guymer, R. H., & Campbell, T. G. (2023) · The Lancet · doi:10.1016/s0140-6736(22)02609-5 · Cited by 502
Self-citationIncomplete Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration
Guymer, R. H., Rosenfeld, P. J., Curcio, C. A., Holz, F. G., Staurenghi, G., Freund, K. B., Schmitz-Valckenberg, S., Sparrow, J., Spaide, R. F., Tufail, A., et al. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2019.09.035 · Cited by 316
Self-citationLutein and Zeaxanthin and Their Roles in Age-Related Macular Degeneration—Neurodegenerative Disease
Mrowicka, M., Mrowicki, J., Kucharska, E., & Majsterek, I. (2022) · Nutrients · doi:10.3390/nu14040827 · Cited by 299
The Diagnosis and Treatment of Age-Related Macular Degeneration
Stahl, A. (2020) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2020.0513 · Cited by 270
Metadata
- Authors
- Guymer, R. H., Wu, Z., Hodgson, L. A. B., Caruso, E., Brassington, K. H., Tindill, N., Aung, K. Z., McGuinness, M. B., Fletcher, E. L., Chen, F. K., Chakravarthy, U., Arnold, J. J., Heriot, W. J., Durkin, S. R., Lek, J. J., Harper, C. A., Wickremasinghe, S. S., Sandhu, S. S., Baglin, E. K., Sharangan, P., Braat, S., & Luu, C. D.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 126
- Issue
- 6
- Pages
- 829-838
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W2891443166
- Cited by
- 208
- References
- 9
- FWCI
- 19.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Subthreshold Nanosecond Laser Intervention in Age-Related Macular Degeneration. https://app.cochat.ai/papers/10.1016/j.ophtha.2018.09.015
- The paper
- Guymer, R. H., Wu, Z., Hodgson, L. A. B., Caruso, E., Brassington, K. H., Tindill, N., Aung, K. Z., McGuinness, M. B., Fletcher, E. L., Chen, F. K., Chakravarthy, U., Arnold, J. J., Heriot, W. J., Durkin, S. R., Lek, J. J., Harper, C. A., Wickremasinghe, S. S., Sandhu, S. S., Baglin, E. K., . . . Luu, C. D. (2019). Subthreshold Nanosecond Laser Intervention in Age-Related Macular Degeneration. Ophthalmology. https://doi.org/10.1016/j.ophtha.2018.09.015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.